TNF Pharmaceuticals, Inc. (TNFA) Dividend History

TNF Pharmaceuticals, Inc. (TNFA) is a biotechnology company focused on developing and commercializing products targeting inflammatory and autoimmune diseases. The company specializes in pioneering therapies that modulate tumor necrosis factor (TNF) pathways, aiming to improve treatment options for patients suffering from chronic inflammatory conditions.

855 N. Wolfe Street, Baltimore, MD, 21205
Phone: 856-848-8698
Website: https://tnfpharma.com

Dividend History

TNF Pharmaceuticals, Inc. currently does not pay dividends

Company News

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The sarcopenia market remains largely untapped, with significant unmet medical needs and no approved drug therapies. However, pharmaceutical interest is rising, particularly around muscle-enhancing agents and anti-inflammatory pathways. Regulatory bodies are beginning to recognize sarcopenia as a distinct clinical condition, which may streamline future drug approvals.

GlobeNewswire Inc.

Featured Companies: LPCN

Page data last updated 07/24/2025 01:22:14 UTC